Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Terminated2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00734435Phase 2Terminated
Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
Schizoaffective DisorderSchizophreniaSchizophreniform Disorder
Principalinvestigator

Research Network

Collaboration Network

19 collaborators·59 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Robert Riesenberg, MD

Atlanta Center for Medical Research

Moderately Similar
4 trials

Shared therapeutic areas:

Obsessive-Compulsive DisorderSchizoaffective DisorderSchizophrenia+1 more

Worked with same sponsors:

Orexigen Therapeutics, Inc
Collaborated on 2 trials
Similarity Score48%

Mohammed Bari, MD

Synergy Research

Moderately Similar
1 trials

Shared therapeutic areas:

Schizoaffective DisorderSchizophreniaSchizophreniform Disorders

Worked with same sponsors:

Orexigen Therapeutics, Inc
Collaborated on 1 trial
Similarity Score34%

Andrew Cutler, MD

Florida Clinical Research Center, Bradenton Florida

Moderately Similar
1 trials

Shared therapeutic areas:

Schizoaffective DisorderSchizophreniaSchizophreniform Disorders

Worked with same sponsors:

Orexigen Therapeutics, Inc
Collaborated on 1 trial
Similarity Score34%

Tran Johnson, MD

CNRI

Moderately Similar
1 trials

Shared therapeutic areas:

Schizoaffective DisorderSchizophreniaSchizophreniform Disorders

Worked with same sponsors:

Orexigen Therapeutics, Inc
Collaborated on 1 trial
Similarity Score34%

Mohammed Alam, MD

American Medical Research

Moderately Similar
1 trials

Shared therapeutic areas:

Schizoaffective DisorderSchizophreniaSchizophreniform Disorders

Worked with same sponsors:

Orexigen Therapeutics, Inc
Collaborated on 1 trial
Similarity Score34%

Alan Breier, MD

Larue D. Carter Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Schizoaffective DisorderSchizophreniaSchizophreniform Disorders

Worked with same sponsors:

Orexigen Therapeutics, Inc
Collaborated on 1 trial
Similarity Score34%

Eduard Gfeller, MD

Florida Clinical Research Center, Maitland Florida

Moderately Similar
1 trials

Shared therapeutic areas:

Schizoaffective DisorderSchizophreniaSchizophreniform Disorders

Worked with same sponsors:

Orexigen Therapeutics, Inc
Collaborated on 1 trial
Similarity Score34%

BioXcel MM, MD

BioXcel Therapeutics

Related
10 trials

Shared therapeutic areas:

SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Similarity Score23%

William Honer, MD

University of British Columbia

Related
7 trials

Shared therapeutic areas:

SchizophreniaSchizoaffective Disorder
Similarity Score15%

Joseph Zohar, MD

Tel Aviv University

Related
12 trials

Shared therapeutic areas:

Obsessive-Compulsive DisorderSchizophrenia
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00734435Phase 2PrincipalInvestigator

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Schizoaffective DisorderSchizophreniaSchizophreniform Disorder
Terminated
NCT00758966Phase 2PrincipalInvestigator

Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder
Terminated

All 2 trials loaded